Risk perceptions of high-dose primaquine and tafenoquine among Plasmodium vivax malaria stakeholders in Ethiopia: a qualitative study.
BMJ Glob Health.
2026 Jun 29;11(6). doi: 10.1136/bmjgh-2025-021763. PubMed PMID:
42373213; PubMed Central PMCID:
PMC13331116.
Predicting Risk of Plasmodium Vivax Microscopy-Detected Episodes Using Serological Markers in Patients With Plasmodium falciparum Malaria: A Multicountry Diagnostic Performance Evaluation.
J Infect Dis.
2026 Jun 16;233(6):e1470-e1479. doi: 10.1093/infdis/jiag164. PubMed PMID:
41846579; PubMed Central PMCID:
PMC13271364.
Clinical perspectives on hemoglobin measurement: The example of malaria radical cure.
PLOS Glob Public Health.
2026;6(6):e0006614. doi: 10.1371/journal.pgph.0006614. eCollection 2026. PubMed PMID:
42302050; PubMed Central PMCID:
PMC13271514.
Analysis of the effect of primaquine dose on efficacy, safety, and tolerability in patients with Plasmodium vivax malaria in Ethiopia: a systematic review and individual patient data meta-analysis.
Malar J.
2026 Jun 6;. doi: 10.1186/s12936-026-05968-z. [Epub ahead of print] PubMed PMID:
42251388.
Dissemination of EFFORT trial results in Indonesia: a stakeholder meeting report on tafenoquine and primaquine for radical cure of Plasmodium vivax.
Malar J.
2026 May 27;25(1). doi: 10.1186/s12936-026-05948-3. PubMed PMID:
42204711; PubMed Central PMCID:
PMC13214447.
Mapping the global distribution and spread of the Plasmodium vivax-associated virus MaRNAV-1.
Virus Evol.
2026;12(1):veag031. doi: 10.1093/ve/veag031. eCollection 2026. PubMed PMID:
42311450; PubMed Central PMCID:
PMC13271372.
Genetic evidence of cross-border Plasmodium vivax spread in a malaria pre-elimination region of South Asia.
J Infect Dis.
2026 May 15;. doi: 10.1093/infdis/jiag268. [Epub ahead of print] PubMed PMID:
42139514.
Comparison of CD4 T-Cell Response in Plasmodium falciparum and vivax Malaria.
J Infect Dis.
2026 Apr 29;233(4):e891-e901. doi: 10.1093/infdis/jiag115. PubMed PMID:
41757944; PubMed Central PMCID:
PMC13127770.
Short-Course Low-Dose Primaquine for Radical Cure in G6PD-Normal Patients in the Pre-Elimination Context of Nepal.
Trop Med Int Health.
2026 Aug;31(8):1028-1034. doi: 10.1111/tmi.70145. Epub 2026 Apr 25. PubMed PMID:
42033147; PubMed Central PMCID:
PMC13432698.
G6PD deficiency in Indonesia: a systematic review and update of prevalence and variant maps in the context of malaria elimination.
Lancet Reg Health West Pac.
2026 Apr;69:101840. doi: 10.1016/j.lanwpc.2026.101840. eCollection 2026 Apr. PubMed PMID:
41953713; PubMed Central PMCID:
PMC13053798.
Chronic Malaria Is Associated With Trauma-related Splenic Rupture Requiring Splenectomy.
J Infect Dis.
2026 Mar 17;233(3):e740-e744. doi: 10.1093/infdis/jiaf629. PubMed PMID:
41378825; PubMed Central PMCID:
PMC13017132.
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial.
Lancet Infect Dis.
2026 Jun;26(6):614-626. doi: 10.1016/S1473-3099(25)00729-7. Epub 2026 Feb 11. PubMed PMID:
41690325; PubMed Central PMCID:
PMC13215974.
Moving towards high-dose primaquine or single-dose tafenoquine for Plasmodium vivax treatment in Cambodia: a meeting report from dissemination of results of the EFFORT trial to stakeholders.
Malar J.
2026 Jan 3;25(1):2. doi: 10.1186/s12936-025-05691-1. PubMed PMID:
41484619; PubMed Central PMCID:
PMC12763851.
Rapid detection of G6PD deficiency SNPs using a novel amplicon-based minion sequencing assay.
Sci Rep.
2025 Dec 21;16(1):2110. doi: 10.1038/s41598-025-31822-4. PubMed PMID:
41423656; PubMed Central PMCID:
PMC12808739.
Enhancing unique identification of patients with malaria using biometric fingerprinting in Papua, Indonesia.
Malar J.
2025 Dec 19;25(1):56. doi: 10.1186/s12936-025-05749-0. PubMed PMID:
41419916; PubMed Central PMCID:
PMC12836991.
Haematologic responses to primaquine used for radical cure of Plasmodium vivax in public health facilities in Ethiopia: a prospective observational study.
Malar J.
2025 Dec 8;25(1):27. doi: 10.1186/s12936-025-05709-8. PubMed PMID:
41361889; PubMed Central PMCID:
PMC12797556.
Systematic review and individual patient data meta-analysis on glucose- 6 - phosphate dehydrogenase activities measured by a semi-quantitative handheld biosensor.
Malar J.
2025 Nov 20;24(1):406. doi: 10.1186/s12936-025-05654-6. PubMed PMID:
41261454; PubMed Central PMCID:
PMC12631995.
Beyond malaria: can intermittent preventive treatment with sulphadoxine-pyrimethamine reduce the number of small vulnerable newborns globally?.
Lancet Glob Health.
2026 Jan;14(1):e157-e163. doi: 10.1016/S2214-109X(25)00405-X. Epub 2025 Nov 17. Review. PubMed PMID:
41265465; PubMed Central PMCID:
PMC13207199.
Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis.
Malar J.
2025 Nov 14;24(1):400. doi: 10.1186/s12936-025-05642-w. PubMed PMID:
41239453; PubMed Central PMCID:
PMC12619205.
Effectiveness of tafenoquine and primaquine for radical cure of Plasmodium vivax: a meeting report from dissemination of results of the EFFORT trial to stakeholders in Pakistan.
Malar J.
2025 Nov 11;24(1):393. doi: 10.1186/s12936-025-05636-8. PubMed PMID:
41219866; PubMed Central PMCID:
PMC12606953.
FocaL mass drug administration for Plasmodium vivax malaria elimination (FLAME): study protocol for an open-label cluster randomized controlled trial in Peru.
Trials.
2025 Oct 14;26(1):408. doi: 10.1186/s13063-025-09112-1. PubMed PMID:
41088393; PubMed Central PMCID:
PMC12522803.
Perceptions of shorter radical cure Plasmodium vivax treatment regimens and their implementation: a qualitative study among stakeholders in Cambodia.
Malar J.
2025 Sep 30;24(1):304. doi: 10.1186/s12936-025-05525-0. PubMed PMID:
41029685; PubMed Central PMCID:
PMC12487259.
Strengthening country ownership of national antimalarial policymaking: insights from Laos, Pakistan and the Solomon Islands.
Malar J.
2025 Sep 2;24(1):283. doi: 10.1186/s12936-025-05510-7. PubMed PMID:
40898135; PubMed Central PMCID:
PMC12403353.
Systems approach identifies monocyte imbalance in symptomatic and asymptomatic P. vivax malaria.
Mol Syst Biol.
2025 Nov;21(11):1434-1465. doi: 10.1038/s44320-025-00135-z. Epub 2025 Aug 19. PubMed PMID:
40830592; PubMed Central PMCID:
PMC12583509.
Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineages.
Nat Commun.
2025 Aug 5;16(1):7192. doi: 10.1038/s41467-025-62357-x. PubMed PMID:
40764298; PubMed Central PMCID:
PMC12325997.
High daily dose Short COurse PrimaquinE after G6PD testing for the radical cure of Plasmodium vivax malaria in Indonesia and Papua New Guinea: the SCOPE implementation study protocol.
BMC Infect Dis.
2025 Jul 16;25(1):922. doi: 10.1186/s12879-025-11109-9. PubMed PMID:
40670924; PubMed Central PMCID:
PMC12265365.
Pf8: an open dataset of Plasmodium falciparum genome variation in 33,325 worldwide samples.
Wellcome Open Res.
2025;10:325. doi: 10.12688/wellcomeopenres.24031.1. eCollection 2025. PubMed PMID:
41267740; PubMed Central PMCID:
PMC12627940.
Rapid detection of G6PD deficiency SNPs using a novel amplicon-based MinION Sequencing Assay.
bioRxiv.
2025 Jun 24;. doi: 10.1101/2025.06.23.661218. PubMed PMID:
40666837; PubMed Central PMCID:
PMC12262242.
Acceptability and feasibility of glucose-6-phosphate dehydrogenase (G6PD) testing using SD Biosensor by village malaria workers in Cambodia: a qualitative study.
BMJ Glob Health.
2025 Jun 16;10(6). doi: 10.1136/bmjgh-2025-019615. PubMed PMID:
40527529; PubMed Central PMCID:
PMC12182016.
Enhanced data quality to improve malaria surveillance in Papua, Indonesia.
Malar J.
2025 Jun 4;24(1):177. doi: 10.1186/s12936-025-05358-x. PubMed PMID:
40468325; PubMed Central PMCID:
PMC12135496.
Co-design of a routine clinical review to improve the safety of high dose radical cure treatment for Plasmodium vivax malaria: findings from Cambodia and Ethiopia.
Malar J.
2025 May 28;24(1):171. doi: 10.1186/s12936-025-05425-3. PubMed PMID:
40437509; PubMed Central PMCID:
PMC12121043.
Malaria morbidity, mortality and associated costs in Indonesia: analysis of the National Health Insurance claim dataset.
BMJ Glob Health.
2025 May 12;10(5). doi: 10.1136/bmjgh-2024-018255. PubMed PMID:
40355266; PubMed Central PMCID:
PMC12083301.
Safety and efficacy of single-dose primaquine to interrupt Plasmodium falciparum malaria transmission in children compared with adults: a systematic review and individual patient data meta-analysis.
Lancet Infect Dis.
2025 Sep;25(9):965-976. doi: 10.1016/S1473-3099(25)00078-7. Epub 2025 Apr 23. PubMed PMID:
40286803; PubMed Central PMCID:
PMC12353880.
How do study participants want to be informed about study results: Findings from a malaria trial in Cambodia, Ethiopia, Pakistan, and Indonesia.
J Clin Transl Sci.
2025;9(1):e83. doi: 10.1017/cts.2025.56. eCollection 2025. PubMed PMID:
40391130; PubMed Central PMCID:
PMC12086731.
Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant data meta-analysis.
PLoS Negl Trop Dis.
2025 Mar;19(3):e0012864. doi: 10.1371/journal.pntd.0012864. eCollection 2025 Mar. PubMed PMID:
40132008; PubMed Central PMCID:
PMC11936200.
Parasitaemia and fever in uncomplicated Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis.
PLoS Negl Trop Dis.
2025 Mar;19(3):e0012951. doi: 10.1371/journal.pntd.0012951. eCollection 2025 Mar. PubMed PMID:
40153391; PubMed Central PMCID:
PMC11978046.
Evaluation of CareStart™ malaria HRP2/pLDH (Pf/PAN) combo rapid diagnostic test for diagnosis of Plasmodium falciparum infection in malaria co-endemic areas in association with parasite density.
Malar J.
2025 Feb 10;24(1):39. doi: 10.1186/s12936-025-05276-y. PubMed PMID:
39930468; PubMed Central PMCID:
PMC11812152.
Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics.
Lancet Infect Dis.
2025 Jun;25(6):668-677. doi: 10.1016/S1473-3099(24)00689-3. Epub 2025 Jan 13. PubMed PMID:
39818221; PubMed Central PMCID:
PMC12095116.
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis.
Lancet Child Adolesc Health.
2024 Nov;8(11):798-808. doi: 10.1016/S2352-4642(24)00210-4. Epub 2024 Sep 24. PubMed PMID:
39332427; PubMed Central PMCID:
PMC11480364.
Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis.
PLoS Med.
2024 Sep;21(9):e1004411. doi: 10.1371/journal.pmed.1004411. eCollection 2024 Sep. PubMed PMID:
39331646; PubMed Central PMCID:
PMC11469483.
Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites.
Nat Commun.
2024 Aug 8;15(1):6757. doi: 10.1038/s41467-024-51015-3. PubMed PMID:
39117628; PubMed Central PMCID:
PMC11310204.
Implementation of Glucose-6-Phosphate Dehydrogenase (G6PD) testing for Plasmodium vivax case management, a mixed method study from Cambodia.
PLOS Glob Public Health.
2024;4(7):e0003476. doi: 10.1371/journal.pgph.0003476. eCollection 2024. PubMed PMID:
39028699; PubMed Central PMCID:
PMC11259306.
Chloroquine has shown high therapeutic efficacy against uncomplicated Plasmodium vivax malaria in southern Ethiopia: seven decades after its introduction.
Malar J.
2024 Jun 10;23(1):183. doi: 10.1186/s12936-024-05009-7. PubMed PMID:
38858696; PubMed Central PMCID:
PMC11165762.
The PreQuine Platform: A novel diagnostic tool for measuring glucose-6-phosphate dehydrogenase (G6PD) activity and hemoglobin concentration.
PLoS One.
2024;19(5):e0297918. doi: 10.1371/journal.pone.0297918. eCollection 2024. PubMed PMID:
38728310; PubMed Central PMCID:
PMC11086878.
On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity.
mBio.
2024 Jun 12;15(6):e0096624. doi: 10.1128/mbio.00966-24. Epub 2024 May 8. PubMed PMID:
38717141; PubMed Central PMCID:
PMC11237774.
Field evaluation of a novel semi-quantitative point-of-care diagnostic for G6PD deficiency in Indonesia.
PLoS One.
2024;19(4):e0301506. doi: 10.1371/journal.pone.0301506. eCollection 2024. PubMed PMID:
38687748; PubMed Central PMCID:
PMC11060553.
Imported malaria into Australia: surveillance insights and opportunities.
J Travel Med.
2024 Apr 6;31(3). doi: 10.1093/jtm/taad164. PubMed PMID:
38127641; PubMed Central PMCID:
PMC10998534.
Evidence uptake is only part of the process: Stakeholders' insights on WHO treatment guideline recommendation processes for radical cure of P. vivax malaria.
PLOS Glob Public Health.
2024;4(3):e0002990. doi: 10.1371/journal.pgph.0002990. eCollection 2024. PubMed PMID:
38483936; PubMed Central PMCID:
PMC10939226.
Progress towards safer and more effective radical cure of Plasmodium vivax.
Lancet Infect Dis.
2024 Jun;24(6):565-567. doi: 10.1016/S1473-3099(24)00139-7. Epub 2024 Mar 4. PubMed PMID:
38452775.
A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India.
Trials.
2024 Feb 29;25(1):154. doi: 10.1186/s13063-024-07987-0. PubMed PMID:
38424577; PubMed Central PMCID:
PMC10905854.
What would you like to do?